Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$492,955
+$3,831 QoQ
Shares Held
1,941
-3.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#3,720
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026M. Kulyk & Associates, LLC holds $37,765,981 across 8 Drug Manufacturers - General names. JNJ ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
94,863 | $12,189,895 | |
| 2 | LLY |
ELI LILLY & Co
|
7,945 | $9,529,472 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
74,859 | $9,457,686 | |
| 4 | NVO |
Novo Nordisk A S
|
93,400 | $4,477,596 | |
| 5 | ABBV |
AbbVie Inc.
|
3,846 | $967,807 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
1,941 | $492,955 | |
| 7 | NVS |
Novartis AG
|
2,439 | $382,240 | |
| 8 | AMGN |
Amgen Inc
|
741 | $268,330 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $492,955 | 1,941 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $489,124 | 2,001 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $395,067 | 1,909 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $353,966 | 1,909 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $287,781 | 1,884 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $313,271 | 1,889 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $260,171 | 1,799 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $710,308 | 4,383 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $639,303 | 4,374 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $716,126 | 4,527 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $519,906 | 3,317 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $534,378 | 3,431 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $586,106 | 3,541 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $597,525 | 3,855 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $707,483 | 4,005 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $515,237 | 3,154 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $558,091 | 3,144 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $600,986 | 3,391 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $547,595 | 3,201 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $530,850 | 3,287 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $523,873 | 3,180 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $618,120 | 3,761 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $495,432 | 3,148 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||